Eli Lilly (LLY) PT Raised to $1,234 at Leerink Partners

January 5, 2026 4:26 AM EST Send to a Friend
Leerink Partners analyst David Risinger raised the price target on Eli Lilly (NYSE: LLY) to $1,234.00 (from $1,104.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login